Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online August 17, 2023.
Article Versions
- You are currently viewing an Earlier version of this article (August 17, 2023 - 09:20).
- View the most recent version of this article
Copyright & Usage
Copyright © 2023 American Society for Pharmacology and Experimental Therapeutics
Author Information
- Minxia Michelle He1,*,
- Sean Xiaochun Zhu2,*,
- Joe R Cannon3,
- Jesper Kammersgaard Christensen4,
- Ruchia Duggal5,
- Mithat Gunduz6,
- Constanze Hilgendorf7,
- Adam Hughes8,
- Ivy Kekessie9,
- Maximilian Kullmann10,
- Dennis Leung9,
- Carsten Terjung11,
- Kai Wang12, and
- Frank Wesche13
- 1Eli Lilly, United States
- 2DMPK, Takeda Pharmaceuticals, United States
- 3BMS, United States
- 4Novo Nordisk, Denmark
- 5Merck, United States
- 6Analytical Sciences/Imaging/Biotransformation, Novartis, United States
- 7DMPK, AstraZeneca R&D Gothenburg, Sweden
- 8GSK, United Kingdom
- 9Genentech, United States
- 10Biontech, Germany
- 11Bayer, Germany
- 12Janssen Research & Development, United States
- 13Boehringer Ingelheim Pharma GmbH & Co KG, Germany
- ↵* Corresponding Author:
Sean Xiaochun Zhu, DMPK, Takeda Pharmaceuticals, 35 Landsdowne St, Cambridge, Massachusetts, 02139, United States. E-mail: xiaochun.zhu{at}takeda.com - * Corresponding Author; email: xiaochun.zhu{at}takeda.com
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement